Vanadate-Induced Inhibition of BCR-Triggered Apoptosis is Coupled with Tyrosine Phosphorylation and Induction of G2M Growth Arrest in Ramos-BL B Cells

REFERENCES

• An S., Knox K. A. Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 1996; 386: 115–122
   PubMed Web of Science ®Google Scholar
• An S., Park I., Rhee C. H., Hong S. I., Knox K. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells. Int. J. Oncol. 2003; 23: 257–268
   Google Scholar
• Asante-Appiah E., Kennedy B. P. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 2003; 284: E663–E670
   PubMed Web of Science ®Google Scholar
• Bouchard P., Zhao Z., Banville D., Dumas F., Fischer E. H., Shen S. H. Phosphorylation and identification of a major tyrosine phosphorylation site in protein tyrosine phosphatase 1C. J. Biol. Chem. 1994; 269: 19585–19589
   PubMedGoogle Scholar
• Bouchon A., Krammer P., Walczak H. Critical role for mitochondria in B cell receptor-mediated apoptosis. Eur. J. Immunol. 2000; 30: 69–77
   PubMed Web of Science ®Google Scholar
• Campbell M. A., Sefton B. M. Protein tyrosine phosphorylation is induced in murine B lymphocytes in response to stimulation with anti-immunoglobulin. EMBO J. 1990; 9: 2125–2131
   PubMed Web of Science ®Google Scholar
• Chen J., Yu W., Bunting K. D., Qu C. K. A negative role of SHP2 tyrosine phosphatase in growth factor-dependent hematopoietic cell survival. Oncogene 2004; 23: 3659–3669
   PubMedGoogle Scholar
• Cuevas B. D., Lu Y., Mao M., Zhang J., LaPushin R., Siminovitch K., Mills G. B. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 2001; 276: 27455–27461
   PubMed Web of Science ®Google Scholar
• Curnock A. P., Knox K. A. LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells. Cell. Immunol. 1998; 187: 77–87
   PubMed Web of Science ®Google Scholar
• Delibrias C. C., Floettmann J., Rowe M., Fearon D. T. Downregulated expression of SHP1 in Burkitt lymphomas and germinal center B lymphocytes. J. Exp. Med. 1997; 186: 1575–1583
   PubMed Web of Science ®Google Scholar
• Ding M., Li1 J.-J., Leonard S. S., Ye J.-P., Shi X., Colburn N. H., Castranova V., Vallyathan V. Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis 1999; 20: 663–668
   PubMed Web of Science ®Google Scholar
• Eeva J., Postila V., Mättö M., Nuutinen U., Ropponen A., Eray M., Pelkonen J. Kinetics and signaling requirements of CD40-mediated protection from B cell receptor-induced apoptosis. Eur. J. Immunol. 2003; 33: 2783–2791
   Google Scholar
• Fuhrmann G. L. C., Rosenberger G., Grusch M., Huettenbrenner S., Halama T., Mosberger I., Sasgary S., Cerni C., Krupitza G. Cdc25A phosphatase suppresses apoptosis induced by serum deprivation. Oncogene 2001; 20: 4542–4553
   PubMedGoogle Scholar
• Gamero A. M., Larner A. C. Vanadate facilitates interferon α-mediated apoptosis that is dependent on the Jak/Stat pathway. J. Biol. Chem. 2001; 276: 13547–13553
   PubMedGoogle Scholar
• Gao N., Ding M., Zheng J. Z., Zhang Z., Leonard S. S., Liu K. J., Shi X., Jiang B. H. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 2002; 277: 31963–31971
   PubMed Web of Science ®Google Scholar
• Heffetz D., Bushkin I., Dror R., Zick Y. The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 1990; 265: 2896–2902
   PubMed Web of Science ®Google Scholar
• Hristov K., Knox K., Mitev V. Regulation of the tyrosine phosphorylation during CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis. Int. J. Oncol. 2005; 16: 937–941
   Google Scholar
• Hsueh R. C., Scheuermann R. S. Tyrosine kinase activation in the decision between growth, differentiation, and death responses initiated from the B cell antigen receptor. Adv. Immunol. 2000; 75: 283–316
   PubMed Web of Science ®Google Scholar
• Huang C., Ding M., Li J., Leonard S. S., Rojanasakul Y., Castranova V., Vallyathan V., Ju G., Shi X. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide. J. Biol. Chem. 2001; 276: 22397–22403
   PubMed Web of Science ®Google Scholar
• Huang C., Zhang Z., Ding M., Li J., Ye J., Leonard S. S., Shen H.-M., Butterworth L., Lu Y., Costa M., Rojanasakul Y., Castranova V., Vallyathan V., Shi X. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J. Biol. Chem. 2000; 275: 32516–32522
   PubMed Web of Science ®Google Scholar
• Huyer G., Liu S., Kelly J., Moffat J., Payette P., Kennedy B., Tsaprailis G., Gresser M. J., Ramachandran C. Mechanism of inhibition of protein-tyrosine phosphatase by vanadate and pervanadate. J. Biol. Chem. 1997; 272: 843–851
   PubMed Web of Science ®Google Scholar
• Ingram J. L., Rice A. B., Santos J., Van Houten B., Bonner J. C. Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases. Am. J. Physiol. Lung Cell Mol. Physiol. 2003; 284: L774–L782
   PubMed Web of Science ®Google Scholar
• Livolsi A., Busuttil V., Imbert V., Abraham R. T., Peyron J.-F. Tyrosine phosphorylation-dependent activation of NF-κB Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur. J. Biochem. 2001; 268: 1508–1515
   PubMedGoogle Scholar
• Lu Y., Yu Q., Liu J. H., Zhang J., Wang H., Koul D., McMurray J. S., Fang X., Yung W. K., Siminovitch K. A., Mills G. B. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J. Biol. Chem. 2003; 278: 40057–40066
   PubMed Web of Science ®Google Scholar
• Lund-Johansen F., Frey T., Ledbetter J. A., Thompson P. A. Apoptosis in hematopoietic cells is associated with an extensive decrease in cellular phosphotyrosine content that can be inhibited by the tyrosine phosphatase antagonist pervanadate. Cytometry 1996; 25: 182–190
   PubMedGoogle Scholar
• Luo J., Sun Y., Lin H., Qian Y., Li Z., Leonard S. S., Huang C., Shi X. Activation of JNK by vanadate induces a Fas-associated death domain (FADD)-dependent death of cerebellar granule progenitors in vitro. J. Biol. Chem. 2003; 278: 4542–4551
   PubMed Web of Science ®Google Scholar
• Mackus W. J. M., Lens S. M. A., Medema R. H., Kwakkenbos M. J., Evers L. M., van Oers M. H. J., van Lier R. A. W., Eldering E. Prevention of B cell antigen receptor-induced apoptosis by ligation of CD40 occurs downstream of cell cycle regulation. Int. Immunol. 2002; 14: 973–982
   PubMed Web of Science ®Google Scholar
• Meurer S., Pioch S., Gross S., Müller-Esterl W. Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase. J. Biol. Chem. 2005; 280: 33149–33156
   PubMed Web of Science ®Google Scholar
• Mizuno K., Tagawa Y., Mitomo K., Watanabe N., Katagiri T., Ogimoto M., Yakura H. Src homology region 2 domain-containing phosphatase 1 positively regulates B cell receptor-induced apoptosis by modulating association of B cell linker protein with Nck and activation of c-Jun NH2-terminal kinase. J. Immunol. 2002; 169: 778–786
   PubMedGoogle Scholar
• Morinville A., Maysinger D., Shaver A. From Vanadis to Atropos: vanadium compounds as pharmacological tools in cell death signalling. Trends Pharmacol. Sci. 1998; 19: 452–460
   PubMed Web of Science ®Google Scholar
• Munoz P., Guma A., Camps M., Furriols M., Testar X., Palacin M., Zorzano A. Vanadate stimulates system A amino acid transport activity in skeletal muscle. Evidence for the involvement of intracellular pH as a mediator of vanadate action. J. Biol. Chem. 1992; 267: 10381–10388
   PubMedGoogle Scholar
• Narla R. K., Dong Y., D'Cruz O. J., Navara C., Uckun F. M. Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent. Clin. Cancer Res. 2000; 6: 1546–1556
   PubMed Web of Science ®Google Scholar
• Otipoby K. L., Draves K., Clark E. A. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP1. J. Biol. Chem. 2001; 276: 44315–44322
   PubMed Web of Science ®Google Scholar
• Paessler M., Kossev P., Tsai D., Raghunath P., Majewski M., Zhang Q., Ramalingam P., Schuster S., Tomaszewski J., Arber D. A., Hsi E., Wasik M. A. Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders. Lab. Invest. 2002; 82: 1599–1606
   Google Scholar
• Papapetropoulos A., Fulton D., Lin M. I., Fontana J., McCabe T. J., Zoellner S., García-Cardeña G., Zhou Z., Gratton J.-P., Sessa W. C. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. Mol. Pharmacol. 2004; 65: 407–415
   Google Scholar
• Posner B. I., Faure R., Burgess J. W., Bevan A. P., Lachance D., Zhang-Sun G., Fantus I. G., Ng J. B., Hall D. A., Lum B. S. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 1994; 269: 4596–4604
   PubMed Web of Science ®Google Scholar
• Register T. C., Wuthier R. E. Effect of vanadate, a potent alkaline phosphatase inhibitor, on 45Ca and 32Pi uptake by matrix vesicle-enriched fractions from chicken epiphyseal cartilage. J. Biol. Chem. 1984; 259: 3511–3518
   PubMed Web of Science ®Google Scholar
• Samet J. M., Silbajoris R., Wu W., Graves L. M. Tyrosine phosphatases as targets in metal-induced signaling in human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 1999; 21: 357–364
   PubMed Web of Science ®Google Scholar
• Seglen P. O., Gordon P. B. Vanadate inhibits protein degradation in isolated rat hepatocytes. J. Biol. Chem. 1981; 256: 7699–7701
   PubMed Web of Science ®Google Scholar
• Somani A. K., Yuen K., Xu F., Zhang J., Branch D. R., Siminovitch K. A. The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells. J. Biol. Chem. 2001; 276: 1938–1944
   PubMedGoogle Scholar
• Swarup G., Speeg K. V., Jr., Cohen S., Garbers D. L. Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J. Biol. Chem. 1982; 257: 7298–7301
   PubMedGoogle Scholar
• Tamura K. R. R., Wipf P., Lazo J. S. Dual G1 and G2/M phase inhibition by SC-alpha alpha delta 9, a combinatorially derived Cdc25 phosphatase inhibitor. Oncogene 1999; 18: 6989–6996
   Google Scholar
• Torossian K., Freedman D., Fantus I. G. Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes. J. Biol. Chem. 1988; 263: 9353–9359
   PubMed Web of Science ®Google Scholar
• Vaananen H. K., Karhukorpi E. K., Sundquist K., Wallmark B., Roininen I., Hentunen T., Tuukkanen J., Lakkakorpi P. Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts. J. Cell Biol. 1990; 111: 1305–1311
   PubMed Web of Science ®Google Scholar
• Wang Y.-Z., Bonner J. C. Mechanism of extracellular signal-regulated Kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts. Am. J. Respir. Cell Mol. Biol. 2000; 22: 590–596
   PubMed Web of Science ®Google Scholar
• Wijkander J., Holst L. S., Rahn T., Resjö S., Castan I., Manganiello V., Belfrage P., Degerman E. Regulation of protein kinase B in rat adipocytes by insulin, vanadate, and peroxovanadate. J. Biol. Chem. 1997; 272: 21520–21526
   PubMed Web of Science ®Google Scholar
• Zhang Z. L. S., Huang C., Vallyathan V., Castranova V., Shi X. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic. Biol. Med. 2003; 34: 1333–1342
   PubMed Web of Science ®Google Scholar